Group One Trading, L.P. Adc Therapeutics Sa Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.66 - $5.29 $4,241 - $13,515	2,555 Added 114.47%	4,787 $21,000
Q3 2023 Nov 09, 2023	BUY	$0.72 - $2.37 $1,538 - $5,064	2,137 Added 2249.47%	2,232 $2,000
Q1 2023 May 12, 2023	SELL	$1.92 - $5.45 $1,545 - $4,387	-805 Reduced 89.44%	95 $0
Q3 2022 Nov 09, 2022	BUY	$4.66 - $10.31 $4,194 - $9,279	900 New	900 $4,000
Q1 2022 May 12, 2022	SELL	$13.28 - $20.03 $1,328 - $2,003	-100 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$19.29 - $31.51 $1,929 - $3,151	100 New	100 $2,000
Q3 2021 Nov 12, 2021	SELL	$20.45 - $30.0 $4,090 - $6,000	-200 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$22.75 - $34.05 $4,550 - $6,809	-200 Reduced 50.0%	200 $5,000
Q4 2020 Feb 10, 2021	BUY	$25.26 - $38.02 $10,104 - $15,208	400 New	400 $13,000

55.1M

82.7K

31.5K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $161M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.